We are live on
!
Find out more
M&G plc Portfolio holdings
AUM
$20.1B
Turnover
14.5%
1-Year Est. Return
16.62%
This Fund
S&P 500
This Quarter
Est. Return
-0.47%
1 Year Est. Return
+16.62%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$19.4B
AUM Growth
-$107M
(-0.55%)
Cap. Flow
-$6.32M
Cap. Flow
% of AUM
-0.03%
Top 10 Holdings %
Top 10 Hldgs %
31.82%
Holding
423
New
51
Increased
131
Reduced
125
Closed
43
Avg Time Held Equity + Options
1.3
years
Top 10 Avg Time Held Equity + Options
1.1
years
Top 20 Avg Time Held Equity + Options
1
year
Avg Time Held Equity only
1.3
years
Top 10 Avg Time Held Equity only
1.1
years
Top 20 Avg Time Held Equity only
1
year
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
AstraZeneca
AZN
|
+$811M |
| 2 |
Microsoft
MSFT
|
+$183M |
| 3 |
Intuit
INTU
|
+$152M |
| 4 |
Broadcom
AVGO
|
+$130M |
| 5 |
The Magnum Ice Cream Company N.V.
MICC
|
+$102M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Lam Research
LRCX
|
+$190M |
| 2 |
Elevance Health
ELV
|
+$109M |
| 3 |
CME Group
CME
|
+$92.3M |
| 4 |
Bristol-Myers Squibb
BMY
|
+$79.9M |
| 5 |
Huazhu Hotels Group
HTHT
|
+$67.8M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 20.64% |
| 2 | Healthcare | 16.38% |
| 3 | Consumer Discretionary | 15.42% |
| 4 | Financials | 11.36% |
| 5 | Communication Services | 6.31% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
301
First Solar
FSLR
$18.9B
| $1.14M | 0.01% |
5,775
| – | – |
2025 Q4
1 quarter
|
|
302
BridgeBio Pharma
BBIO
$12.9B
| $1.11M | 0.01% |
15,041
| – | – |
2025 Q4
1 quarter
|
|
303
CVS Health
CVS
$118B
| $1.11M | 0.01% |
15,356
+2,782
| +22% | +$214K |
2024 Q1
8 quarters
|
|
304
Ionis Pharmaceuticals
IONS
$7.15B
| $1.08M | 0.01% |
14,423
| – | – |
2025 Q4
1 quarter
|
|
305
Ecolab
ECL
$81B
| $1.07M | 0.01% |
4,033
-117
| -3% | -$33K |
2024 Q1
8 quarters
|
|
306
Starbucks
SBUX
$110B
| $1.03M | 0.01% |
11,445
-11,790
| -51% | -$1.12M |
2024 Q3
6 quarters
|
|
307
Atlassian
TEAM
$52.7B
| $1.02M | 0.01% |
+14,986
| New | +$1.48M |
2026 Q1
0 quarters
|
|
308
Advanced Micro Devices
AMD
$884B
| $985K | 0.01% |
4,854
+2,005
| +70% | +$428K |
2024 Q3
6 quarters
|
|
309
Target
TGT
$70.3B
| $977K | 0.01% |
8,077
| – | – |
2024 Q2
7 quarters
|
|
310
Welltower
WELL
$169B
| $948K | ﹤0.01% |
4,786
+34
| +0.7% | +$6.72K |
2024 Q2
7 quarters
|
|
311
Mesoblast
MESO
$1.73B
| $887K | ﹤0.01% |
+59,100
| New | +$984K |
2026 Q1
0 quarters
|
|
312
Klaviyo
KVYO
$4.84B
| $814K | ﹤0.01% |
42,818
| – | – |
2025 Q3
2 quarters
|
|
313
Roper Technologies
ROP
$37.7B
| $724K | ﹤0.01% |
+2,046
| New | +$755K |
2026 Q1
0 quarters
|
|
314
Axon Enterprise
AXON
$32.5B
| $702K | ﹤0.01% |
1,651
-4,909
| -75% | -$2.55M |
2024 Q1
8 quarters
|
|
315
EchoStar
ECHO
$24.9B
| $658K | ﹤0.01% |
+5,624
| New | +$645K |
2026 Q1
0 quarters
|
|
316
Autoliv
ALV
$8.4B
| $550K | ﹤0.01% |
5,236
| – | – |
2024 Q1
8 quarters
|
|
317
Iron Mountain
IRM
$33.6B
| $530K | ﹤0.01% |
5,193
+230
| +5% | +$22.9K |
2025 Q4
1 quarter
|
|
318
Realty Income
O
$53B
| $516K | ﹤0.01% |
8,457
+4,265
| +102% | +$267K |
2024 Q4
5 quarters
|
|
319
Progyny
PGNY
$2.08B
| $477K | ﹤0.01% |
28,082
-848
| -3% | -$18.2K |
2024 Q1
8 quarters
|
|
320
VICI Properties
VICI
$26B
| $416K | ﹤0.01% |
15,403
+682
| +5% | +$19.5K |
2024 Q3
6 quarters
|
|
321
Veralto
VLTO
$24.5B
| $402K | ﹤0.01% |
4,566
+366
| +9% | +$34.8K |
2024 Q4
5 quarters
|
|
322
Xylem
XYL
$24.4B
| $387K | ﹤0.01% |
3,229
+275
| +9% | +$36.1K |
2024 Q1
8 quarters
|
|
323
Sunrun
RUN
$1.78B
| $387K | ﹤0.01% |
27,655
| – | – |
2025 Q4
1 quarter
|
|
324
Yum China
YUMC
$15.2B
| $383K | ﹤0.01% |
7,826
| – | – |
2024 Q1
8 quarters
|
|
325
Edwards Lifesciences
EW
$49.9B
| $373K | ﹤0.01% |
4,661
| – | – |
2024 Q1
8 quarters
|
|
Similar funds
SA
BBA
M&G plc's Q1 2026 Portfolio in Review
As of Q1 2026, M&G plc held 423 positions worth $19.4B, down 0.55% from $19.5B the previous quarter. Its ten largest holdings account for 32% of the portfolio.
M&G plc's Q1 2026 filing shows 51 new, 131 increased, 125 reduced and 43 closed positions. Its largest new stake was AstraZeneca: 4,204,199 shares worth $817M. The largest sale was Lam Research, an estimated $190M.
By sector, the portfolio is most concentrated in Technology at 21% of assets, down from 22% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- M&G plc's largest Q1 2026 buy was AstraZeneca: 4,204,199 shares worth $817M.
- M&G plc added most to Microsoft in Q1 2026, an estimated $183M increase.
- M&G plc's biggest Q1 2026 reduction was Lam Research, cutting an estimated $190M.
- M&G plc fully exited Crown Castle in Q1 2026, selling an estimated $34M.
- M&G plc's ten largest holdings make up 32% of its $19.4B portfolio in Q1 2026.
- M&G plc opened 51 new positions and closed 43 in Q1 2026.
- M&G plc's portfolio value fell 0.55% quarter-over-quarter to $19.4B.
Based on M&G plc's 13F filing for Q1 2026, filed 13 May 2026.